News 9 Oct 2026 DNDi 2026 Projects of the Year recognize teams and partners for their work to advance an open-science antiviral for future coronavirus pandemics and a single-dose treatment for sleeping sickness
Scientific articles 9 Oct 2026 A Perspective on Biomarkers, Candidates for Surrogate End Points to Accelerate Successful Development of New Antiparasitic Agents for the Treatment of Chronic Chagas Disease ACS Infectious Diseases
Press releases 6 Oct 2026 Ghana’s KNUST and DNDi partner to accelerate drug discovery for neglected diseases in Africa
Scientific articles 5 Oct 2026 Winning the endgame against sleeping sickness: Efficacy profiling of acoziborole against African trypanosomes with the focus on Trypanosoma brucei rhodesiense PLoS Neglected Tropical Diseases
Statements 25 Sep 2026 DNDi intervention at the UN High-Level Meeting on Pandemic Prevention, Preparedness, and Response at the 81st UN General Assembly
In the media 24 Sep 2026 De Etiopía a Lleida: la desigualdad mata tanto como los virus durante una pandemia El País
Scientific articles 22 Sep 2026 Efficacy and safety of alternative benznidazole and nifurtimox regimens for adults with chronic Trypanosoma cruzi infection (TESEO): an open-label, randomised, non-inferiority phase 2b trial The Lancet Infection Diseases
Scientific articles 19 Sep 2026 Thermotherapy compared with intralesional sodium stibogluconate for Leishmania aethiopica cutaneous Leishmaniasis in Ethiopia: A phase II randomized controlled trial BMC Medicine
News 15 Sep 2026 New DNDi report: Implementing Article 9.5 of the WHO Pandemic Agreement – building on current policy and practice for publicly funded R&D
In the media 9 Sep 2026 Des acteurs pharmaceutiques à but non lucratif s’allient pour faire face à la baisse des financements Swissinfo
Scientific articles 1 Sep 2026 Analysis of the therapeutic gap for Trypanosoma cruzi infection inColombia (2012 – 2022) Memórias do Instituto Oswaldo Cruz
Viewpoints 29 Jan 2022 Maladies tropicales négligées : les succès méconnus de la recherche congolaise Jeune Afrique
Viewpoints 24 Dec 2021 The moonshot: crowdsourcing to develop the first open-source, generic COVID-19 antiviral pill Health Policy Watch
Viewpoints 16 Dec 2021 L’accès aux médicaments pour les maladies de la pauvreté : enjeu crucial, mission impossible? Société Francophone de Médecine Tropical et Santé Internationale
Viewpoints 1 Dec 2021 There will be new COVID-19 drugs. Will we use them to save the most lives? The New York Times
Viewpoints 6 Aug 2021 Will science deliver needed therapeutics for COVID-19—and how can equitable access be ensured? British Medical Journal (BMJ)
Viewpoints 8 Mar 2021 Gender-responsive R&D, women in science, and access to COVID-19 health tools: DNDi Board Chair Marie-Paule Kieny on International Women’s Day
Viewpoints 30 Jan 2021 Innovation and collaboration can help to eliminate neglected tropical diseases (NTD) The Economic Times
Viewpoints 30 Jan 2021 ¿Ciencia a dos velocidades? Un llamamiento por las enfermedades tropicales desatendidas El Pais
Viewpoints 29 Jan 2021 L’extraordinaire mobilisation scientifique autour du Covid-19 doit aussi s’appliquer aux « maladies négligées » La Croix
Viewpoints 29 Jan 2021 The UK must take the lead in wiping out the world’s forgotten diseases The Telegraph
Viewpoints 29 Jan 2021 Innovation – and research – are key to killing off neglected tropical diseases in Africa The Conversation
